Method for High Efficiency in Vivo Gene Editing
Invention type: Technology
/
Case number: #17117H
The present disclosure relates to compositions and methods for modifying a gene sequence, and for systems for delivering such compositions. For example, the disclosure relates to modifying a gene sequence using a CRISPR-Cas9 or other nucleic acid editing system, and methods and delivery systems for achieving such gene modification, such as viral or non-viral delivery systems.
Researchers
Tyler Jacks
/
Hao Yin
/
Joseph Dorkin
/
Wen Xue
/
Daniel Anderson
Departments: David H Koch Institute for Integrative Cancer Res, Department of Chemical Engineering
Technology Areas: Biotechnology: DNA & RNA Editing / Drug Delivery: Vectors & Virus like Particles / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living
-
method for gene editing
United States of America | Granted | 12,163,124 -
method for gene editing
United States of America | Granted | 10,941,395 -
delivery systems and kits for gene editing
United States of America | Granted | 10,047,355
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.